Natco Pharma has decided to price Risdiplam, indicated for the treatment of rare genetic disorder Spinal Muscular Atrophy (SMA), at₹15,900. In an update on the legal proceedings on the ...

Natco Pharma on April 8 said that the launch of its generic version of Roche Pharma's patented drug, Risdiplam, is contingent upon the successful outcome in a patent infringement case.

Drugmaker Natco Pharma on Tuesday said it intends to launch its generic version of spinal muscular atrophy drug Risdiplam only after and subject to successful clarity from the Appellate Bench of ...

Natco Pharma on Tuesday shared a legal update on the legal proceedings on the Risdiplam compound (used for treating spinal muscular atrophy) launch in India. "The company has received numerous ...

Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹826.85. The stock has experienced fluctuations today, with a low ...

Pharma index surged over 4 per cent in early trade on Thursday after US President Donald Trump’s administration exempted pharmaceutical products from reciprocal tariffs. Market and industry ...

Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US ...

Natco Home Logo Natco Home Logo "As the last standing woven rug manufacturer in the USA, we are excited and proud to incorporate the Orian Rugs brand into the Natco Home fold and look forward to ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

On Thursday's session Nifty Pharma surged nearly 4% with Gland Pharma, Lupin, Aurobindo Pharma, Natco Pharma, Sun Pharmaceutical Industries leading the gains. Rajesh Bhosale, Equity Technical and ...

Gland Pharma, Natco Pharma and JB Chemicals and Pharmaceuticals shares touched a new low intra-day on the NSE. Cipla shares on BSE touched 52-week low. The decline in the shares prices of the 20 ...